Kilroy Realty
KRC NYSE Office REITs Financials FY2016βFY2025
Kilroy Realty's revenue fell 2.0% to $1.1 billion in fiscal 2025. Its net margin was 27.2%, up from 20.5% a year earlier. Free cash flow was $450 million, up 2.1%. It paid out $258 million in dividends and buybacks, 57% of free cash flow. The diluted share count rose 0.6%.
About these figures. Interest coverage for 2025 is left blank: Kilroy's 2025 filing has no pre-tax income line to measure it from.
What Kilroy Realty does
No business description yet.
- Legal name
- KILROY REALTY CORP
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001628280-26-007051
0001025996
Revenue and margins
Kilroy Realty had $1.1B of revenue in fiscal 2025, down 2.0% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew β2.7% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $450M in fiscal 2025, 40.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Kilroy Realty returned $258M to shareholders in fiscal 2025, 57% of free cash flow. The diluted share count rose 0.6%.
Value Kilroy Realty yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β and divides by 118.8M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 20.4x Β· peers β Β· sector 28.2x.
Balance sheet
Cash, debt and the ratios that show how comfortably Kilroy Realty can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $414M | $347M | $510M | $166M | $179M |
| Interest coverage | 9.4x | 4.1x | 3.1x | 2.6x | β |
| Total assets | $10.6B | $10.8B | $11.4B | $10.9B | $10.9B |
| Total liabilities | $4.9B | $5.1B | $5.7B | $5.3B | $5.3B |
| Shareholders' equity | $5.4B | $5.4B | $5.4B | $5.4B | $5.4B |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$2.6M
5 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 29, 2026 | Jolie A. HuntDirector | Sold | 15,800 | $37.79 | $0.6M | Form 4 |
| Jun 24, 2026 | Paratte A. RobertSee Remarks | Sold | 8,000 | $37.34 | $0.3M | Form 4 |
| Jun 9, 2026 | Justin William SmartPresident | Sold | 10,848 | $38.71 | $0.4M | Form 4 |
| May 7, 2026 | Heidi Rena RothSee Remarks | Sold | 19,541 | $35.22 | $0.7M | Form 4 |
| May 6, 2026 | Lauren N StadlerSee Remarks | Sold | 3,000 | $34.65 | $0.1M | Form 4 |
| Apr 30, 2026 | Paratte A. RobertSee Remarks | Sold | 10,000 | $33.11 | $0.3M | Form 4 |
| Oct 31, 2025 | Heidi Rena RothSee Remarks | Sold | 3,944 | $41.99 | $0.2M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | β / 9 | β / 9 |
| Accruals ratio | β3.3% | β2.8% | β2.4% |
| Altman Z'' | β | β | β |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Kilroy Realty KRC | $4.4B | β2.0% | β | 40.5% | β | 20.4x | β | |
| Cousins Properties CUZ | $4.8B | 16.0% | 67.8% | 13.6% | 6.7% | β | β | Compare β |
| COPT Defense Properties CDP | $3.9B | 1.4% | β | 37.8% | 6.1% | 23.6x | β | Compare β |
| Vornado Realty Trust VNO | $6.8B | 1.3% | β | 53.1% | 17.4% | β | β | Compare β |
| Alexandria Real Estate Equities ARE | $7.3B | β2.9% | β | β15.1% | β | β | β | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $643M | $719M | $747M | $838M | $898M | $955M | $1.1B | $1.1B | $1.1B | $1.1B |
| Interest expense | $55.8M | $66.0M | $49.7M | $48.5M | $70.8M | $78.6M | $84.3M | $114M | $145M | $126M |
| Pretax income | $294M | $165M | $258M | $195M | $207M | $659M | $260M | $238M | $233M | β |
| Income tax | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | β |
| Net income | $294M | $165M | $258M | $195M | $207M | $659M | $260M | $238M | $233M | $303M |
| Diluted EPS | $2.97 | $1.51 | $2.55 | $1.86 | $1.63 | $5.36 | $1.97 | $1.80 | $1.77 | $2.32 |
| Diluted shares | 0.09B | 0.10B | 0.10B | 0.10B | 0.11B | 0.12B | 0.12B | 0.12B | 0.12B | 0.12B |
| Cash flow | ||||||||||
| Cash from operations | $345M | $347M | $410M | $387M | $456M | $516M | $592M | $603M | $541M | $566M |
| Capital expenditure | $112M | $88.4M | $166M | $148M | $130M | $121M | $92.8M | $97.4M | $100M | $116M |
| Free cash flow | $233M | $259M | $244M | $239M | $326M | $396M | $499M | $505M | $441M | $450M |
| Depreciation and amortization | $213M | $242M | $250M | $268M | $290M | $304M | $351M | $348M | $350M | $349M |
| Stock-based compensation | $21.1M | $19.0M | $27.9M | $27.0M | $30.2M | $33.8M | $28.3M | $36.9M | $17.7M | $19.1M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends paid | $137M | $341M | $179M | $196M | $225M | $237M | $248M | $255M | $256M | $258M |
| Dividends and buybacks | $137M | $341M | $179M | $196M | $225M | $237M | $248M | $255M | $256M | $258M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $193M | $57.6M | $51.6M | $60.0M | $732M | $414M | $347M | $510M | $166M | $179M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Total assets | $6.7B | $6.8B | $7.8B | $8.9B | $10.0B | $10.6B | $10.8B | $11.4B | $10.9B | $10.9B |
| Total liabilities | $2.9B | $2.8B | $3.6B | $4.3B | $4.7B | $4.9B | $5.1B | $5.7B | $5.3B | $5.3B |
| Shareholders' equity | $3.5B | $3.7B | $3.9B | $4.3B | $5.0B | $5.4B | $5.4B | $5.4B | $5.4B | $5.4B |
| Margins | ||||||||||
| EBITDA margin | 87.6% | 65.7% | 74.7% | 61.1% | 63.3% | 109.0% | 63.3% | 62.0% | 64.1% | β |
| Net margin | 45.7% | 22.9% | 34.6% | 23.3% | 23.1% | 69.0% | 23.7% | 21.1% | 20.5% | 27.2% |
| FCF margin | 36.3% | 36.0% | 32.6% | 28.5% | 36.3% | 41.4% | 45.5% | 44.7% | 38.8% | 40.5% |
| Returns | ||||||||||
| Return on equity | 8.8% | 4.5% | 6.8% | 4.8% | 4.5% | 12.6% | 4.8% | 4.4% | 4.3% | 5.6% |
| Return on assets | 4.7% | 2.4% | 3.6% | 2.4% | 2.2% | 6.4% | 2.4% | 2.2% | 2.1% | 2.8% |
| Growth | ||||||||||
| Revenue growth | β | 11.9% | 3.9% | 12.1% | 7.3% | 6.3% | 14.9% | 3.0% | 0.5% | β2.0% |
| Net income growth | 25.5% | β44.0% | 57.0% | β24.4% | 6.1% | 217.9% | β60.6% | β8.2% | β2.2% | 29.9% |
| EPS growth | 22.7% | β49.2% | 68.9% | β27.1% | β12.4% | 228.8% | β63.3% | β8.6% | β1.7% | 31.1% |
| FCF growth | 35.2% | 10.9% | β5.8% | β2.0% | 36.5% | 21.4% | 26.2% | 1.2% | β12.7% | 2.1% |
| Share count change | 2.9% | 6.1% | 1.8% | 3.4% | 9.5% | 2.8% | 0.2% | 0.2% | 0.6% | 0.6% |
| Financial health | ||||||||||
| Interest coverage | 6.3x | 3.5x | 6.2x | 5.0x | 3.9x | 9.4x | 4.1x | 3.1x | 2.6x | β |
| Capital allocation | ||||||||||
| Capex / revenue | 17.4% | 12.3% | 22.3% | 17.6% | 14.4% | 12.6% | 8.5% | 8.6% | 8.8% | 10.4% |
| Stock comp / revenue | 3.3% | 2.7% | 3.7% | 3.2% | 3.4% | 3.5% | 2.6% | 3.3% | 1.6% | 1.7% |
| Payouts / FCF | 59.0% | 131.8% | 73.7% | 82.2% | 68.9% | 60.0% | 49.6% | 50.6% | 58.1% | 57.3% |
| Quality scores | ||||||||||
| Accruals ratio | β0.8% | β2.7% | β2.1% | β2.3% | β2.6% | 1.4% | β3.1% | β3.3% | β2.8% | β2.4% |
Source: SEC EDGAR XBRL filings (CIK 0001025996). Data updated October 17, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.